CRISPR legend Jennifer Doudna helps some recent college grads launch a diagnostics upstart
A group of recent and current grad students in the Bay Area have come together to launch a new company that promises to use CRISPR technology to create a lineup of diagnostic tests that may one day make diagnosing cancer or malaria or most anything a snap.
And aside from the tech they’ve in-licensed out of Berkeley, the young entrepreneurs have one big asset in their favor. Jennifer Doudna, one of the most famous scientific pioneers behind CRISPR/Cas9 gene editing tech, is coming on board as a co-founder.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters